SGS North America Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 75 Passaic Ave, Fairfield, New Jersey (NJ) 07004, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 2214690 · DUNS 808308303
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-06-09
- VAIDrug Quality Assurance2023-08-01
- NAIDrug Quality Assurance2017-08-30
- NAIDrug Quality Assurance2016-06-07
- VAIDrug Quality Assurance2014-01-21
- NAIDrug Quality Assurance2011-11-21
- NAIDrug Quality Assurance2011-04-07
- VAIDrug Quality Assurance2010-01-14
Drugs this plant is listed as making
3 distinct drugs across 9 products name this site in their FDA label.
- delafloxacin meglumineMelinta Therapeutics, LLC
- Eflornithine HydrochlorideUswm, Llc
- morphine sulfatein shortageNortec Development Associates, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.